Downloadable Slidesets

Share

Program Content

Activities

  • Biomarkers in AML
    Biological Markers for Predicting Outcomes in Acute Myeloid Leukemia
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

  • Immunotherapy in AML
    Targeting Antigens in AML: New Advances in Antibody–Drug Conjugates and Other Antibody-Based Therapies
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

  • FLT3- and IDH1/2-Mutant AML
    Available and Emerging Treatment Options in IDH-Mutant and FLT3-Mutant AML
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

  • Investigational AML Agents
    Future Directions for Novel Therapeutic Agents in AML
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

  • Treating ND AML
    Overcoming Treatment Challenges in Patients With Newly Diagnosed AML
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

Faculty

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Ellen K. Ritchie, MD

Associate Professor
Division of Hematology and Oncology
Department of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Eytan M. Stein, MD

Chief, Leukemia Service
Director, Program for Drug Development in Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Agios Pharmaceuticals

Boston Biomedical

Celgene TEXT Only

Daiichi Sankyo, Inc.